ASKA Pharmaceutical Holdings CO., Ltd. (4886) Other

Market cap
¥78.3B
P/E ratio
15.5x
Asuka Pharmaceutical Holdings operates through subsidiaries that manufacture prescription drugs, veterinary medicines, and medical devices for healthcare providers globally.
2022/032023/032024/032025/03
Return on Assets-58.55.3
Return on equity (%)
Employees7777477621,632
AI Chat